July 26, 2021 | |
Name of listed company: Chugai Pharmaceutical Co., Ltd. | |
Code number: | 4519 (1st Section of Tokyo Stock Exchange) |
Head office: | 1-1,Nihonbashi-Muromachi2-Chome,Chuo-ku, Tokyo |
President & CEO: | Osamu Okuda |
Inquiries to: | Toshiya Sasai |
Head of Corporate Communications Dept. | |
Tel: +81-(0)3-3273-0554 |
F. Hoffmann-La Roche Announces Half Year Results 2021
F. Hoffmann-La Roche Ltd. (hereafter "Roche") [Head Office: Basel, Switzerland. CEO: Severin Schwan] announced its half year results 2021 (January 1 - June 30, 2021) on July 22, 2021 (local time).
Roche owns 59.89% of Chugai's outstanding shares (61.16% of the total number of shares issued excluding treasury stock) as of the end of June 2021.
Its press release and presentation materials can be found on its website (https://www.roche.com).
Chugai's performance for the period of January 1 to June 30, 2021 is included in the announced Roche Group's results.
Investor Updates | Presentations | Half-Year Report 2021 |
###
Attachments
- Original document
- Permalink
Disclaimer
Chugai Pharmaceutical Co. Ltd. published this content on 26 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 July 2021 23:37:09 UTC.